SilverCrest Metals
SILV
Cars.com
CARS
Lantheus
LNTH
Collegium Pharmaceutical
COLL
和黃醫藥
HCM
(Q2)2024/08/31 | (Q1)2024/05/31 | (FY)2024/02/29 | (Q4)2024/02/29 | (Q3)2023/11/30 | (Q2)2023/08/31 | (Q1)2023/05/31 | (FY)2023/02/28 | (Q4)2023/02/28 | (Q3)2022/11/30 | |
---|---|---|---|---|---|---|---|---|---|---|
營業總收入 | -3.53%4.74億 | -12.18%4.17億 | -3.26%20.05億 | 0.95%4.89億 | -1.61%5.5億 | -5.72%4.92億 | -6.57%4.75億 | -6.78%20.73億 | -16.74%4.85億 | -10.61%5.59億 |
營業收入 | -3.53%4.74億 | -12.18%4.17億 | -3.26%20.05億 | 0.95%4.89億 | -1.61%5.5億 | -5.72%4.92億 | -6.57%4.75億 | -6.78%20.73億 | -16.74%4.85億 | -10.61%5.59億 |
主營業務成本 | -1.44%2.58億 | -17.48%2.14億 | -9.97%10.56億 | -9.08%2.5億 | -5.33%2.86億 | -12.68%2.62億 | -12.75%2.59億 | -7.63%11.73億 | -17.77%2.75億 | -13.99%3.02億 |
毛利 | -5.91%2.16億 | -5.82%2.03億 | 5.48%9.49億 | 14.06%2.4億 | 2.77%2.64億 | 3.71%2.3億 | 2.11%2.16億 | -5.65%8.99億 | -15.36%2.1億 | -6.27%2.57億 |
營業費用 | 0.28%1.8億 | 1.70%1.7億 | 1.39%6.69億 | 17.57%1.7億 | -9.50%1.53億 | 5.58%1.79億 | -5.41%1.68億 | -2.95%6.6億 | -27.08%1.44億 | -8.04%1.69億 |
銷售和管理費用 | 0.28%1.8億 | 1.70%1.7億 | 1.39%6.69億 | 17.57%1.7億 | -9.50%1.53億 | 5.58%1.79億 | -5.41%1.68億 | -2.95%6.6億 | -27.08%1.44億 | -8.04%1.69億 |
營業利潤 | -27.91%3,637.8萬 | -32.08%3,259.8萬 | 16.79%2.79億 | 6.37%7,002.6萬 | 26.42%1.11億 | -2.44%5,046.2萬 | 41.41%4,799.6萬 | -12.38%2.39億 | 30.66%6,583.4萬 | -2.65%8,765.6萬 |
淨非營業利息收入(費用) | 3.21%-1,321.6萬 | 10.74%-1,254.3萬 | -30.22%-5,306.5萬 | 11.11%-1,250萬 | 2.21%-1,285.9萬 | -48.96%-1,365.4萬 | -221.34%-1,405.2萬 | -217.28%-4,075.1萬 | -321.55%-1,406.3萬 | -310.14%-1,314.9萬 |
利息費用 | -3.21%1,321.6萬 | -10.74%1,254.3萬 | 30.22%5,306.5萬 | -11.11%1,250萬 | -2.21%1,285.9萬 | 48.96%1,365.4萬 | 221.34%1,405.2萬 | 217.28%4,075.1萬 | 321.55%1,406.3萬 | 310.14%1,314.9萬 |
其他淨收入(費用) | 60.91%-135.6萬 | 75.96%-173.5萬 | 36.58%-1,719.4萬 | 76.80%-279.7萬 | 64.52%-371萬 | 25.61%-346.9萬 | -11,204.62%-721.8萬 | -22,494.17%-2,711.3萬 | -16,176.00%-1,205.7萬 | -22,351.06%-1,045.8萬 |
特殊收入(費用) | 57.81%-152.6萬 | 75.05%-183.5萬 | 31.61%-1,871.2萬 | 68.24%-385萬 | 62.82%-389萬 | 24.27%-361.7萬 | -367,650.00%-735.5萬 | -7,100.53%-2,736.2萬 | ---1,212.1萬 | -209,160.00%-1,046.3萬 |
-減:重組與併購 | -57.81%152.6萬 | -75.05%183.5萬 | -31.61%1,871.2萬 | -68.24%385萬 | -62.82%389萬 | -24.27%361.7萬 | 367,650.00%735.5萬 | 7,100.53%2,736.2萬 | --1,212.1萬 | 209,160.00%1,046.3萬 |
其他非經營收入(費用) | 14.86%17萬 | -27.01%10萬 | 509.64%151.8萬 | 1,545.31%105.3萬 | 3,500.00%18萬 | 30.97%14.8萬 | 104.48%13.7萬 | -4.23%24.9萬 | -14.67%6.4萬 | -90.38%5,000 |
稅前利潤 | -34.59%2,180.6萬 | -31.45%1,832萬 | 22.04%2.09億 | 37.81%5,472.9萬 | 47.15%9,424.8萬 | -12.02%3,333.9萬 | -9.81%2,672.6萬 | -34.11%1.71億 | -15.72%3,971.4萬 | -26.28%6,404.9萬 |
所得稅 | -19.57%479.2萬 | 192.30%1,211.6萬 | 44.37%4,044.8萬 | 239.42%1,199.5萬 | 50.13%1,835萬 | -17.49%595.8萬 | -17.73%414.5萬 | -22.61%2,801.6萬 | -51.78%353.4萬 | 9.10%1,222.3萬 |
除稅後利潤 | -37.86%1,701.4萬 | -72.53%620.4萬 | 17.67%1.69億 | 18.11%4,273.4萬 | 46.45%7,589.8萬 | -10.73%2,738.1萬 | -8.19%2,258.1萬 | -35.97%1.43億 | -9.08%3,618萬 | -31.52%5,182.6萬 |
持續經營利潤 | -37.86%1,701.4萬 | -72.53%620.4萬 | 17.67%1.69億 | 18.11%4,273.4萬 | 46.45%7,589.8萬 | -10.73%2,738.1萬 | -8.19%2,258.1萬 | -35.97%1.43億 | -9.08%3,618萬 | -31.52%5,182.6萬 |
歸屬於少數股東的淨利潤 | ||||||||||
歸屬於母公司的淨利潤 | -37.86%1,701.4萬 | -72.53%620.4萬 | 17.67%1.69億 | 18.11%4,273.4萬 | 46.45%7,589.8萬 | -10.73%2,738.1萬 | -8.19%2,258.1萬 | -35.97%1.43億 | -9.08%3,618萬 | -31.52%5,182.6萬 |
優先股派息 | ||||||||||
其他優先股派息 | ||||||||||
歸屬於普通股股東的淨利潤 | -37.86%1,701.4萬 | -72.53%620.4萬 | 17.67%1.69億 | 18.11%4,273.4萬 | 46.45%7,589.8萬 | -10.73%2,738.1萬 | -8.19%2,258.1萬 | -35.97%1.43億 | -9.08%3,618萬 | -31.52%5,182.6萬 |
基本每股收益 | -34.21%0.75 | -72.34%0.26 | 18.06%7.06 | 18.71%1.79 | 48.15%3.2 | -10.94%1.14 | -8.74%0.94 | -35.49%5.98 | -9.82%1.5079 | -31.21%2.16 |
稀釋每股收益 | -35.09%0.74 | -72.34%0.26 | 18.15%7.03 | 18.67%1.78 | 48.37%3.19 | -10.94%1.14 | -7.84%0.94 | -35.11%5.95 | -8.54%1.5 | -30.65%2.15 |
每股派息 | ||||||||||
貨幣單位 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
會計準則 | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
審計意見 | -- | -- | 無保留意見 | -- | -- | -- | -- | 無保留意見 | -- | -- |